Code of Massachusetts Regulations
105 CMR - DEPARTMENT OF PUBLIC HEALTH
Title 105 CMR 240.000 - Criteria For Insurance Coverage Of Bone Marrow Transplants For Breast Cancer Patients
Section 240.006 - Suitable Clinical Trials

Universal Citation: 105 MA Code of Regs 105.240

Current through Register 1531, September 27, 2024

The health care providers and insurers specified in 105 CMR 240.003 shall provide coverage for bone marrow transplantation, in accordance with 105 CMR 240.000, where the patient has been found to meet the eligibility criteria for a clinical trial satisfying the requirements of 105 CMR 240.006. The clinical trial shall be conducted in accordance with a protocol approved by an institutional review board meeting the requirements for the protection of human subjects specified in 45 CFR Part 46. In addition, the clinical trial shall be conducted:

(A) at a licensed health facility which is located at the principal site of an academic medical center which participates in NCI sponsored or approved research in any cancer specialty area; or

(B) at a licensed health facility which has a formal affiliation agreement with an academic medical center to provide bone marrow transplantation as part of an NCI sponsored or approved research protocol.

Disclaimer: These regulations may not be the most recent version. Massachusetts may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.